http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3048699-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81cd1dab144ceac45be974b127d78c63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-739 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 1980-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab116ef861b662bc6a1def072fab4ca |
| publicationDate | 1982-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3048699-A1 |
| titleOfInvention | "IMMUNOTHERAPEUTIC AGENT, SUITABLE AGAINST TURMOR, CONTAINING A LIPOPOLYSACCHARID AS AN ACTIVE INGREDIENT" |
| abstract | Immunossimulant contains as effective component lipopolysaccharide where polysaccharide chain in arabinomannane is obtd. by extracting Mycobacterium tuberculosis Aoyama B strain or Mycobacterium tuberculosis H37Rv strain with hot water and purifying the extract. The content of a fatty acid in ester bond is 1-28%. Alternatively the effective component lipopolysaccharide is of fatty acid content of 1-28% where fatty acid is bonded in a suitable ratio to the arabinomannane. Or the fatty acid is further bonded in a suitable ratio to lipopolysaccharide bonded with fatty acid in ester bond. Fatty acid is a residue of palmitic, myristic, stearic, tubercurostearic, heptadecanoic, oleic or linolic acids. The saccharide compsn. is arabinose 30-74%, mannose 20-50%, glucose 0-10%, galactose 0-13%. Method is an immunostiluent used as anti-cancer remedy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3407823-A1 |
| priorityDate | 1980-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.